Helen Cunliffe

Deallus

Deallus is a global life science consultancy with a heritage in Competitive Intelligence. Our vision is to lead the industry in shaping and refining strategies for those striving to advance healthcare and improve patients' lives. For two decades Deallus has been the partner of choice for pharma, biotech, and med-tech to help our clients achieve this. Today we work alongside the world's global leading pharma companies, as well as emerging biopharma, partnering with our clients across multiple projects and over many years. We are a team of commercial scientists which allows for a peer-to-peer partnerships with our clients through a shared understanding of how science intersects with commercial market realities. For our clients we become an extension of their internal teams, enabling us to generate bespoke solutions to organisational needs and ambitions. Operating in key pharma markets, we retain and develop top talent, nurturing our team by cultivating a diverse and inclusive culture. Clients value our expertise in market dynamics and depth of therapeutic areas to deliver the actionable insights that drive innovation. We're proud of the part we've played in helping clients prepare for the future, achieve competitive advantage and allowing their organisations to remain at the forefront of the industry. Our therapy area expertise, including neuroscience, oncology, rare diseases, and vaccines, and our global reach serve clients areas including: business insights, market access, value and pricing, R&D, portfolio strategy, medical affairs, and brand and marketing. Our outputs are tailored to the client challenge and leveraging a range of methodologies including primary research, market landscaping, workshops, and forecasting.